carnitine has been researched along with trinitrobenzenesulfonic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calvani, M; Calvani, R; Caporaso, N; Casamassimi, A; Ciccodicola, A; D'Argenio, G; Margarucci, S; Peluso, G; Peluso, I; Petillo, O; Rienzo, M | 1 |
Bitton, A; Collette, C; Fortin, G; Franchimont, D; Rubio, M; Sarfati, M; Villani, AC; Yurchenko, K | 1 |
Abdolghaffari, AH; Abdollahi, M; Baeeri, M; Ghasemi-Niri, SF; Moeinian, M; Mozaffari, S; Navaea-Nigjeh, M | 1 |
3 other study(ies) available for carnitine and trinitrobenzenesulfonic acid
Article | Year |
---|---|
Experimental colitis: decreased Octn2 and Atb0+ expression in rat colonocytes induces carnitine depletion that is reversible by carnitine-loaded liposomes.
Topics: Amino Acid Sequence; Amino Acid Transport System ASC; Animals; Base Sequence; Butyric Acid; Carnitine; Colitis; Liposomes; Molecular Sequence Data; Neurotransmitter Transport Proteins; Organic Cation Transport Proteins; Rats; Rats, Wistar; Solute Carrier Family 22 Member 5; Trinitrobenzenesulfonic Acid | 2006 |
L-carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation.
Topics: Animals; Carnitine; CD4-Positive T-Lymphocytes; Cells, Cultured; Colitis; Cytokines; Dendritic Cells; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Immunologic; Drug Evaluation, Preclinical; Immunosuppressive Agents; Inflammation Mediators; Lipopolysaccharides; Lymphocyte Activation; Macrophages; Male; Mice; Mice, Inbred BALB C; Organic Cation Transport Proteins; Solute Carrier Family 22 Member 5; Spleen; Trinitrobenzenesulfonic Acid | 2009 |
Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Butyric Acid; Carnitine; Colitis; Colon; Combined Modality Therapy; Disease Models, Animal; Gastrointestinal Agents; Inflammation Mediators; Lacticaseibacillus casei; Male; Oxidative Stress; Probiotics; Rats, Wistar; Time Factors; Trinitrobenzenesulfonic Acid | 2014 |